You are browsing the archive for Bausch & Lomb - peHUB.

Ten Hot Stories: VC Returns Improve a Bit, Better Place Goes Belly Up and LPs Talk Straight to VCs

Posted on: May 31, 2013 by Lawrence J. AragonNo Comments »

Trending on peHUB this week: VC returns, straight-talking LPs, tech M&A, Better Place, NEA, Valeant, Bausch & Lomb, Mary Meeker, Kleiner Perkins, Andreessen Horowitz, Yahoo, Tumblr, Warburg Pincus, Adeo Ressi

Warburg to Make Nearly 3x its Money on Bausch & Lomb Sale

Posted on: May 28, 2013 by Luisa BeltranNo Comments »

Warburg Pincus looks like it will nearly triple its investment once it sells Bausch & Lomb to Valeant Pharmaceuticals.

Report: Warburg to Seek IPO for Bausch & Lomb

Posted on: January 29, 2013 by Luisa BeltranNo Comments »

Warburg Pincus is pursuing a dual track process for Bausch & Lomb.

Slideshow: Middle Market Deals Down in Q1, Houlihan Emerges as Top Advisor

Posted on: April 16, 2012 by Luisa BeltranNo Comments »

Middle market M&A slides in Q1. Plus a slideshow of top 3 PE-backed middle market deals.

AcuFocus Inks $65 Million

Posted on: November 30, 2011 by asormaniNo Comments »

AcuFocus a maker of corneal inlay, has closed a $65 million financing round led by Cowen Healthcare Royalty Partners. Existing investors SV Life Sciences, Versant Ventures, Carlyle Group, Accuitive Medical Ventures and Bausch & Lomb participated, with Medtronic also joining in the round. Cowen Royalty’s $30 million investment included a $25 million Synthetic Royalty(SM) investment [...]